Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Characterisation of VDR signaling in prostate cancer health disparities (RNA-Seq BAZ1A conditional)

ABSTRACT: Characterisation of VDR signaling in prostate cancer health disparities (RNA-Seq BAZ1A conditional)

PROVIDER: PRJNA925938 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23173820_1.fastq.gz	Fastqsanger.gz
	SRR23173820_2.fastq.gz	Fastqsanger.gz
	SRR23173821_1.fastq.gz	Fastqsanger.gz
	SRR23173821_2.fastq.gz	Fastqsanger.gz
	SRR23173822_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 97

Similar Datasets

Characterisation of VDR signaling in prostate cancer health disparities

Project description:Characterisation of VDR signaling in prostate cancer health disparities

| PRJNA925935 | ENA

Characterisation of VDR signaling in prostate cancer health disparities (ATAC-Seq)

Project description:Characterisation of VDR signaling in prostate cancer health disparities (ATAC-Seq)

| PRJNA915406 | ENA

Characterisation of VDR signaling in prostate cancer health disparities (RNA-Seq)

Project description:Characterisation of VDR signaling in prostate cancer health disparities (RNA-Seq)

| PRJNA915377 | ENA

Characterisation of VDR signaling in prostate cancer health disparities (ChIP-Seq)

Project description:Characterisation of VDR signaling in prostate cancer health disparities (ChIP-Seq)

| PRJNA916260 | ENA

Characterisation of VDR signaling in prostate cancer health disparities (small RNA-Seq)

Project description:Characterisation of VDR signaling in prostate cancer health disparities (small RNA-Seq)

| PRJNA925488 | ENA

Characterisation of VDR signaling in prostate cancer health disparities (ChIP-Seq)

Project description:To investigate the effect of 1,25(OH)2D3 activation on VDR genomic binding in prostate cell lines derived from European Americans and African Americans

2023-01-16 | GSE221826 | GEO

Characterisation of VDR signaling in prostate cancer health disparities (RNA-Seq; BAZ1A conditional)

Project description:To investigate the effect of 1,25(OH)2D3 activation on RNA expression in prostate cell lines derived from European Americans and African Americans

2023-01-31 | GSE223405 | GEO

Uncovering the role admixture in health disparities: Association of hepatocyte gene expression and DNA methylation to African Ancestry in African-Americans [Methylation]

Project description:In African Americans (AA), the proportion of West African ancestry (WAA) may explain the genetic drivers of health disparities in disease. Analysis of RNA sequencing data from sixty AA-derived primary hepatocytes identified 32 gene expression profiles associated with WAA (FDR <0.05) with enrichment in angiogenesis and inflammatory pathways (FDR <0.1). Association of DNA methylation to WAA identified 1037 differentially methylated regions (FDR <0.05), with hypomethylated genes enriched for drug response pathways. Within the PharmGKB pharmacogene, VDR, PTGIS, ALDH1A1, CYP2C19 and P2RY1 were associated with WAA (p <0.05) with replication of CYP2C19 and VDR in the GTEx liver cohort. For every 1% increment in WAA, P2RY1 gene expression increased by 1.6% and CYP2C19 gene expression decreased by 1.4%, suggesting effects on clopidogrel response and platelet aggregation. We conclude that WAA contributes to variablity in hepatic gene expression and DNA methylation with identified genes indicative of health disparities prevalent in AAs.

2019-10-31 | GSE123995 | GEO

Uncovering the role admixture in health disparities: Association of hepatocyte gene expression and DNA methylation to African Ancestry in African-Americans [RNA-seq]

2023-01-10 | GSE222593 | GEO

Uncovering the role admixture in health disparities: Association of hepatocyte gene expression and DNA methylation to African Ancestry in African-Americans [RNA-seq]

2019-10-31 | GSE124074 | GEO